TY - JOUR
T1 - Letter to the Editor : Lack of evidence for the effect of oxytocin on placebo analgesia and nocebo hyperalgesia
AU - LIU, Cuizhen
AU - HUANG, Yi
AU - CHEN, Linqiu
AU - YU, Rongjun
PY - 2020/5
Y1 - 2020/5
N2 - A placebo response refers to the improvement in a patient's clinical symptoms when administered with an inert substance, whereas a nocebo response is the worsening of clinical symptoms. The neuropeptide oxytocin is implicated in social trust, stress/anxiety, and learning processes that also contribute to placebo and nocebo responses. This leads to an intriguing hypothesis that pharmacological manipulation of oxytocin 1nay modulate placebo/nocebo. It has been proposed that oxytocin may enhance social trust, a key element of the patient-doctor relationship, which may further boost placebo effects. Oxytocin has also been shown to be involved in reducing stress and anxiety, which might contribute significantly to the magnitude of nocebo.
AB - A placebo response refers to the improvement in a patient's clinical symptoms when administered with an inert substance, whereas a nocebo response is the worsening of clinical symptoms. The neuropeptide oxytocin is implicated in social trust, stress/anxiety, and learning processes that also contribute to placebo and nocebo responses. This leads to an intriguing hypothesis that pharmacological manipulation of oxytocin 1nay modulate placebo/nocebo. It has been proposed that oxytocin may enhance social trust, a key element of the patient-doctor relationship, which may further boost placebo effects. Oxytocin has also been shown to be involved in reducing stress and anxiety, which might contribute significantly to the magnitude of nocebo.
UR - http://www.scopus.com/inward/record.url?scp=85077475033&partnerID=8YFLogxK
U2 - 10.1159/000504967
DO - 10.1159/000504967
M3 - Journal Article (refereed)
C2 - 31865357
AN - SCOPUS:85077475033
SN - 0033-3190
VL - 89
SP - 185
EP - 187
JO - Psychotherapy and Psychosomatics
JF - Psychotherapy and Psychosomatics
IS - 3
ER -